Start Date
August 1, 2017
Primary Completion Date
August 1, 2017
Study Completion Date
August 1, 2017
Cyclophosphamide
Treatment for all patients will be with cyclophosphamide, lenalidomide and pembrolizumab at fixed doses.
Lenalidomide
Treatment for all patients will be with cyclophosphamide, lenalidomide and pembrolizumab at fixed doses.
Pembrolizumab
Treatment for all patients will be with cyclophosphamide, lenalidomide and pembrolizumab at fixed doses.
Queen Elizabeth Hospital, Birmingham
University College Hospital, London
Guys and St Thomas NHS Foundation Trust, London
Southampton General Hospital, Southampton
Collaborators (1)
Myeloma UK
OTHER
Karyopharm Therapeutics Inc
INDUSTRY
University of Leeds
OTHER